The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

SPINT2  -  serine peptidase inhibitor, Kunitz type, 2

Homo sapiens

Synonyms: DIAR3, HAI-2, HAI2, Hepatocyte growth factor activator inhibitor type 2, KOP, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of SPINT2

 

Psychiatry related information on SPINT2

  • The form of the test amino acid (CAA = crystalline, PB = protein-bound) had little effect on choice behavior, but sudden transfer of WCS from a PB acclimation diet to test diets with a large total CAA concentration increased the latency of effective choice by 2-3 days [6].
 

High impact information on SPINT2

  • As activating mutations in the MET proto-oncogene (the HGF receptor) cause familial RCC, we investigated whether HAI-2/SPINT2 might act as a RCC tumor suppressor gene [1].
  • Following treatment with a demethylating agent, 5 of 11 renal cell carcinoma (RCC) cell lines showed increased expression of hepatocyte growth factor (HGF) activator inhibitor type 2 (HAI-2/SPINT2/Bikunin), a Kunitz-type protease inhibitor that regulates HGF activity [1].
  • We found that transcriptional silencing of HAI-2 in RCC cell lines was associated with promoter region methylation and HAI-2/SPINT2 protein expression was down-regulated in 30% of sporadic RCC [1].
  • The primary translation product of HAI-2 has a hydrophobic sequence in the COOH-terminal region, suggesting that, like HAI-1, HAI-2 is produced in a membrane-associated form and secreted in a proteolytically truncated form [7].
  • The cDNA sequence revealed that HAI-2 is derived from a precursor protein of 252 amino acids and contains two Kunitz domains, indicating that HAI-2 is also a member of the Kunitz family of serine protease inhibitors [7].
 

Chemical compound and disease context of SPINT2

  • During the course of acetic acid-induced murine experimental colitis, HAI-1, but not HAI-2, was indeed upregulated in the recovery phase [8].
  • Previous microarray analysis demonstrated that 14 genes, including hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI2/PB) gene, showed particularly high inductions after 5-aza-2'deoxycytidine (5Aza-dC) treatment in multiple hepatoma cell lines [9].
  • Purification and characterization of protein PB of betaine reductase and its relationship to the corresponding proteins glycine reductase and sarcosine reductase from Eubacterium acidaminophilum [10].
  • The influence of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU), caffeic acid oxidation product (KOP), and trisodiumphosphonoformate (TPF) on the course of the primary cutaneous herpes simplex virus infection was investigated by means of a guinea pig test model [11].
  • Pneumonias were polymicrobial in the absence of antibiotics, due to PCN-sensitive organisms in the topical PB group, and due to gram-negative bacilli in the IV PCN/GM group [12].
 

Biological context of SPINT2

 

Anatomical context of SPINT2

 

Associations of SPINT2 with chemical compounds

  • A point mutation in the COOH-terminal Kunitz domain did not affect the activity of HAI-2, whereas a point mutation in the NH2-terminal Kunitz domain markedly reduced the activity [18].
  • Diffusion coefficients of PY and PB, of their complexes, and of rhodamine 110 are given and compared to those of similar molecules [19].
  • Additionally, high levels of HAI-2 were a significant predictor for poor clinical complete response to preoperative epirubicin in univariate (P = 0.01) and multivariate analyses (P = 0.016) [20].
  • We found that this peptide can also fold into a helix H1 conformation when dissolved in a TFE/PB mixture [21].
  • The latter subunits cross-reacted with antibodies raised against PB betaine and showed high sequence similarity to the 45-kDa and 48-kDa subunits of PB betaine, respectively [10].
 

Regulatory relationships of SPINT2

 

Other interactions of SPINT2

 

Analytical, diagnostic and therapeutic context of SPINT2

References

  1. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Morris, M.R., Gentle, D., Abdulrahman, M., Maina, E.N., Gupta, K., Banks, R.E., Wiesener, M.S., Kishida, T., Yao, M., Teh, B., Latif, F., Maher, E.R. Cancer Res. (2005) [Pubmed]
  2. The hepatocyte growth factor regulatory factors in human breast cancer. Parr, C., Watkins, G., Mansel, R.E., Jiang, W.G. Clin. Cancer Res. (2004) [Pubmed]
  3. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Parr, C., Jiang, W.G. Int. J. Cancer (2006) [Pubmed]
  4. Serum hepatocyte growth factor activator inhibitor type I (HAI-I) and type 2 (HAI-2) in prostate cancer. Nagakawa, O., Yamagishi, T., Akashi, T., Nagaike, K., Fuse, H. Prostate (2006) [Pubmed]
  5. Differential expression of bikunin (HAI-2/PB), a proposed mediator of glioma invasion, by demethylation treatment. Schuster, J.M., Longo, M., Nelson, P.S. J. Neurooncol. (2003) [Pubmed]
  6. Sparrows discriminate between diets differing in valine or lysine concentrations. Murphy, M.E., King, J.R. Physiol. Behav. (1989) [Pubmed]
  7. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. Kawaguchi, T., Qin, L., Shimomura, T., Kondo, J., Matsumoto, K., Denda, K., Kitamura, N. J. Biol. Chem. (1997) [Pubmed]
  8. Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa. Itoh, H., Kataoka, H. J. Gastroenterol. (2002) [Pubmed]
  9. Identification and investigation of methylated genes in hepatoma. Chiba, T., Yokosuka, O., Fukai, K., Hirasawa, Y., Tada, M., Mikata, R., Imazeki, F., Taniguchi, H., Iwama, A., Miyazaki, M., Ochiai, T., Saisho, H. Eur. J. Cancer (2005) [Pubmed]
  10. Purification and characterization of protein PB of betaine reductase and its relationship to the corresponding proteins glycine reductase and sarcosine reductase from Eubacterium acidaminophilum. Meyer, M., Granderath, K., Andreesen, J.R. Eur. J. Biochem. (1995) [Pubmed]
  11. Therapeutic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, caffeic acid oxidation product, and trisodiumphosphonoformate on cutaneous herpes simplex virus type 1 infection in guinea pigs. Helbig, B., Sauerbrei, A., Klöcking, R., Wutzler, P., Wicht, N., Wiedemann, U., Herrmann, G. J. Med. Virol. (1987) [Pubmed]
  12. Prevention of nosocomial pneumonia using topical and parenteral antimicrobial agents. Johanson, W.G., Seidenfeld, J.J., de los Santos, R., Coalson, J.J., Gomez, P. Am. Rev. Respir. Dis. (1988) [Pubmed]
  13. Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes. Itoh, H., Yamauchi, M., Kataoka, H., Hamasuna, R., Kitamura, N., Koono, M. Eur. J. Biochem. (2000) [Pubmed]
  14. Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: identification of a distinct transcription start site for the HAI-2 gene in testis. Yamauchi, M., Itoh, H., Naganuma, S., Koono, M., Hasui, Y., Osada, Y., Kataoka, H. Biol. Chem. (2002) [Pubmed]
  15. Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis. Marchand-Adam, S., Fabre, A., Mailleux, A.A., Marchal, J., Quesnel, C., Kataoka, H., Aubier, M., Dehoux, M., Soler, P., Crestani, B. Am. J. Respir. Crit. Care Med. (2006) [Pubmed]
  16. Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa. Itoh, H., Kataoka, H., Tomita, M., Hamasuna, R., Nawa, Y., Kitamura, N., Koono, M. Am. J. Physiol. Gastrointest. Liver Physiol. (2000) [Pubmed]
  17. Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma. Yamauchi, M., Kataoka, H., Itoh, H., Seguchi, T., Hasui, Y., Osada, Y. J. Urol. (2004) [Pubmed]
  18. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 2. Qin, L., Denda, K., Shimomura, T., Kawaguchi, T., Kitamura, N. FEBS Lett. (1998) [Pubmed]
  19. Fluorescence correlation spectroscopy, a tool to investigate supramolecular dynamics: inclusion complexes of pyronines with cyclodextrin. Al-Soufi, W., Reija, B., Novo, M., Felekyan, S., Kühnemuth, R., Seidel, C.A. J. Am. Chem. Soc. (2005) [Pubmed]
  20. Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer. Generali, D., Fox, S.B., Berruti, A., Moore, J.W., Brizzi, M.P., Patel, N., Allevi, G., Bonardi, S., Aguggini, S., Bersiga, A., Campo, L., Dogliotti, L., Bottini, A., Harris, A.L. Clin. Cancer Res. (2007) [Pubmed]
  21. Possible role of region 152-156 in the structural duality of a peptide fragment from sheep prion protein. Megy, S., Bertho, G., Kozin, S.A., Debey, P., Hoa, G.H., Girault, J.P. Protein Sci. (2004) [Pubmed]
  22. Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains. Marlor, C.W., Delaria, K.A., Davis, G., Muller, D.K., Greve, J.M., Tamburini, P.P. J. Biol. Chem. (1997) [Pubmed]
  23. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Fukai, K., Yokosuka, O., Chiba, T., Hirasawa, Y., Tada, M., Imazeki, F., Kataoka, H., Saisho, H. Cancer Res. (2003) [Pubmed]
 
WikiGenes - Universities